Proceedings: Selective suppression of spleen B lymphocytes following treatment with Escherichia coli lipoproteinpolysaccharide-containing adjuvants.
D000276:Adjuvants, Immunologic / Q000494:pharmacology*; D000818:Animals; D000917:Antibody Formation / Q000187:drug effects; D000942:Antigens, Bacterial; D001402:B-Lymphocytes / Q000187:drug effects*; D004926:Escherichia coli / Q000276:immunology; D007166:Immunosuppressive Agents / Q000494:pharmacology; D051379:Mice; D013154:Spleen / Q000166:cytology*
D000276:Adjuvants, Immunologic; D000942:Antigens, Bacterial; D007166:Immunosuppressive Agents